相关实验视频

Updated: May 23, 2025

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

针对骨髓发育综合征进行血造干细胞移植的患者的结局

Sujith Karumathil¹, Uday Kulkarni¹, Sushil Selvarajan¹

¹Department of Clinical Haematology, Christian Medical College, Vellore, India.

Blood cell therapy

|March 10, 2025

概括

造血干细胞移植 (HSCT) 提供了治疗髓质疏松症候群 (MDS) 的方法. 虽然结果正在改善,特别是在匹配的兄弟捐赠者身上,但为了获得更好的结果,需要采取减少移植对宿主疾病和感染的策略,以获得替代捐赠者的更好的结果.

科学领域:

血液学血液学血液学
在瘤学瘤学.
移植医学移植医学移植医学

背景情况:

骨髓发育综合征 (MDS) 是一组克隆性造血干细胞疾病.
造血干细胞移植 (HSCT) 是MDS的唯一潜在的治愈治疗方法.
评估长期结果和影响MDSHSCT后生存的因素至关重要.

研究的目的:

在30年的时间内,评估MDS患者的HSCT结果.
确定与MDS HSCT后的整体存活率 (OS) 和无事件存活率 (EFS) 相关的因素.
根据捐赠者类型,调节强度和患者年龄来比较结果.

主要方法:

在1991年至2021年期间接受HSCT的154名MDS患者的回顾性分析.
收集有关患者人口统计,疾病风险,调节方案,捐赠者类型,移植来源和并发症的数据.
统计分析,包括多变量分析,以确定生存的预测因素.

主要成果:

五年总生存率 (OS) 和无事件生存率 (EFS) 分别为41.69%和40.8%.
与替代捐赠者相比,与人类白细胞抗原匹配相关捐赠者 (MRD) 的结局明显好 (45%对29%).
儿童在5年后的生存状况 (71%) 显著改善. 与较差的生存状况相关的因素包括年龄,小/双向血型不匹配,和单一血型相同的捐赠者.

结论:

对MDS的HSCT结果是合理的,特别是对MRDs,并且随着时间的推移显示出改善.
接受来自替代捐赠者的移植患者的生存率需要提高.
对减少移植对宿主病 (GVHD) 和感染的策略进行进一步的研究是有必要的,以提高HSCT在MDS中的疗效.

关键词:

在 MDS MDS 中.干细胞移植干细胞移植结果就是结果.

更多相关视频

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...